Valeo Pharma Inc.
VPHIF
$0.0469
-$0.0471-50.11%
07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.16M | 5.01M | 7.16M | 5.40M | 7.43M |
Total Receivables | 3.46M | 4.08M | 3.84M | 4.73M | 4.07M |
Inventory | 4.86M | 4.81M | 7.25M | 7.38M | 9.79M |
Prepaid Expenses | 322.90K | 948.80K | 463.40K | 669.60K | 637.80K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 13.80M | 14.85M | 18.72M | 18.18M | 21.93M |
|
|||||
Total Current Assets | 13.80M | 14.85M | 18.72M | 18.18M | 21.93M |
Net Property, Plant & Equipment | 1.79M | 1.86M | 1.96M | 1.92M | 2.13M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 7.10M | 7.79M | 8.37M | 8.42M | 9.27M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 626.20K | 654.10K | 1.11M | 1.15M | 1.29M |
Total Assets | 23.31M | 25.16M | 30.16M | 29.67M | 34.62M |
|
|||||
Total Accounts Payable | 7.30M | 6.21M | 7.16M | 2.87M | 7.79M |
Total Accrued Expenses | 2.16M | 1.88M | 1.67M | 1.73M | 1.50M |
Short-term Debt | 2.47M | 2.30M | 2.60M | 2.01M | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 30.58M | 26.37M | 20.38M | 1.35M | 54.00K |
Total Finance Division Other Current Liabilities | 8.10M | 7.20M | 6.75M | 6.63M | 3.07M |
Total Other Current Liabilities | 8.10M | 7.20M | 6.75M | 6.63M | 3.07M |
Total Current Liabilities | 50.61M | 43.96M | 38.55M | 14.60M | 12.41M |
|
|||||
Total Current Liabilities | 50.61M | 43.96M | 38.55M | 14.60M | 12.41M |
Long-Term Debt | 17.22M | 19.98M | 25.63M | 43.02M | 47.64M |
Short-term Debt | 2.47M | 2.30M | 2.60M | 2.01M | -- |
Capital Leases | 933.90K | 950.20K | 987.40K | 961.20K | 1.03M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 170.90K | 180.40K | 125.60K | 128.90K | 177.10K |
Total Liabilities | 68.94M | 65.08M | 65.30M | 58.71M | 61.26M |
|
|||||
Common Stock & APIC | 26.45M | 26.57M | 27.26M | 26.12M | 24.60M |
Retained Earnings | -76.11M | -70.54M | -66.62M | -59.23M | -55.51M |
Treasury Stock & Other | 4.03M | 4.05M | 4.23M | 4.07M | 4.27M |
Total Common Equity | -45.63M | -39.92M | -35.14M | -29.04M | -26.64M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -45.63M | -39.92M | -35.14M | -29.04M | -26.64M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -45.63M | -39.92M | -35.14M | -29.04M | -26.64M |
|